U.S. market Closed. Opens in 2 hours 53 minutes

XERS | Xeris Biopharma Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue163.91M110.25M110.25M49.59M20.16M2.46M1.56M1.07M
Cost of Revenue39.49M22.63M22.63M13.32M9.33M42.00K4.00K8.00K
Gross Profit124.43M87.61M87.61M36.27M10.83M2.42M1.55M1.07M
Operating Expenses168.44M169.55M169.55M151.43M94.37M61.77M28.18M14.30M
Selling, General & Admin146.09M137.75M137.75M125.72M73.73M21.11M8.02M4.06M
Research & Development22.34M20.97M20.97M25.16M20.92M40.65M20.17M10.24M
Other Operating Expenses10.84M-14.14M10.84M550.00K-280.00KN/AN/AN/A
Operating Income-44.01M-81.94M-81.94M-115.16M-83.55M-59.34M-26.63M-13.23M
Other Expenses / Income-19.49M-14.14M-14.14M-7.57M-7.70M196.00K75.00K22.00K
Before Tax Income-63.50M-96.08M-96.08M-122.72M-91.25M-60.08M-26.55M-13.21M
Income Tax Expenses-1.25M-1.42M-1.42M-110.00K-110.00K1.81MN/AN/A
Net Income-62.26M-94.66M-94.66M-122.72M-91.14M-60.08M-26.55M-13.21M
Interest Expenses26.61M15.32M15.32M7.18M10.66M2.54M2.00K2.00K
Basic Shares Outstanding137.67M135.63M79.03M42.64M26.11M12.05M11.36M2.17M
Diluted Shares Outstanding137.67M135.63M79.03M42.64M26.11M12.05M11.36M2.17M
EBITDA-30.85M-71.10M-71.10M-114.61M-80.58M-57.73M-26.38M-13.09M
EBITDA Margin-18.82%-64.49%-64.49%-231.11%-399.81%-2,342.03%-1,695.05%-1,217.77%
EBIT-36.90M-80.76M-80.76M-115.66M-80.59M-55.73M-26.55M-13.21M
EBIT Margin-22.51%-73.25%-73.25%-233.22%-399.85%-2,260.69%-1,706.43%-1,228.56%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙